BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4119702)

  • 21. [Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin].
    Bitter K
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1973 Feb; 60(2):81-93. PubMed ID: 4122694
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
    Fries R; Wilfert KH
    Osterr Z Erforsch Bekampf Krebskr; 1973; 28(1):29-32. PubMed ID: 4123658
    [No Abstract]   [Full Text] [Related]  

  • 23. Progression of squamous carcinoma in situ of the vulva to invasive carcinoma after systemic bleomycin therapy.
    Ostor AG; Sfameni SF; Kneale BL; Fortune DW
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):55-8. PubMed ID: 6204633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined treatment for carcinoma of the paranasal sinuses with irradiation and bleomycin.
    Matsumura Y; Soda T; Motomura K
    Eye Ear Nose Throat Mon; 1973 Jan; 52(1):4-11. PubMed ID: 4122365
    [No Abstract]   [Full Text] [Related]  

  • 25. [Concurrent radiochemotherapy of primary squamous cell carcinoma of the vulva].
    Bahnsen J
    Strahlenther Onkol; 1996 May; 172(5):278-9. PubMed ID: 8633263
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of the clinical efficiency of bleomycin in human cancer.
    Clinical Screening Co-operative Group of the European Organization for Research on the Treatment of Cancer
    Br Med J; 1970 Jun; 2(5710):643-5. PubMed ID: 5429108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A preliminary report of the Chinese Corynebacterium vaccine with pingyangmycin on the treatment of squamous cell carcinoma of the oral and maxillofacial region].
    Zhou ZY
    Zhonghua Kou Qiang Ke Za Zhi; 1984 Dec; 19(4):199-202. PubMed ID: 6085726
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bleomycin, a new antitumour antibiotic in the treatment of neoplastic diseases].
    Christensen L
    Wien Klin Wochenschr; 1972 Nov; 84(46):737-43. PubMed ID: 4117777
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Beecham J; DiSaia PJ
    Cancer Treat Rep; 1987 Sep; 71(9):869-70. PubMed ID: 3621221
    [No Abstract]   [Full Text] [Related]  

  • 30. [The efficacy and side effects of the preoperative administration of pingyangmycin in squamous cell carcinoma of the oro-maxillo-facial region].
    Zhao FY
    Zhonghua Kou Qiang Ke Za Zhi; 1985 May; 20(3):150-3, 190-1. PubMed ID: 2417789
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical use of peplomycin in esophageal cancer].
    Hirai T; Takiyama W; Miyoshi Y; Hattori T; Yamagata S; Ohya M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1249-55. PubMed ID: 6191710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin and irradiation effects on the esophageal carcinoma; a preliminary histological evaluation.
    Soga J; Fujimaki M; Kawaguchi M; Tazawa K; Maeda M
    Acta Med Biol (Niigata); 1971 Sep; 19(2):119-36. PubMed ID: 4112403
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chronic osteomyelitis with skin cancer--administration of bleomycin].
    Shiraishi S
    Seikei Geka; 1971 Nov; 22(12):1071-5. PubMed ID: 4110451
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of gynecologic tumors with a new antineoplastic agent, bleomycin (BLM). 2. Clinical study of bleomycin].
    Suzuki M; Ito M; Nomura H; Kasematsu T; Nakanishi K
    Sanfujinka No Jissai; 1969 Jun; 18(6):574-81. PubMed ID: 5820206
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of oral and maxillofacial squamous cell carcinomas by zhenguangmycin---with discussion on the similarities and differences between zhenguangmycin and bleomycin (author's transl)].
    Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun; 14(2):77-9. PubMed ID: 95503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experiences with pepleomycin].
    Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
    Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathologic study of the selective therapeutic effect of pingyangmycin on squamous cell carcinoma (author's transl)].
    Xian MS; Wu QG; Bian XX; Sun RQ; Liu AR; Zhang BL
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):167-71. PubMed ID: 95445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and histopathological study on chemotherapy of maxillary cancer with special reference to bleomycin].
    Takasaki K
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Jul; 74(7):1129-47. PubMed ID: 4106057
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of pepleomycin in prostatic cancer. A preliminary report.
    Niijima T; Koiso K
    Scand J Urol Nephrol Suppl; 1980; 55():177-9. PubMed ID: 6163206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bleomycin, an antimitotic antibiotic, in the treatment of ORL and cervico-facial epidermoid epitheliomas].
    Guement JM
    Maroc Med; 1972 Nov; 52(562):667-71. PubMed ID: 4124583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.